Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Escherichia coli. EAEC, EHEC, EIEC, ETEC.

P H Gilligan1

  • 1Clinical Microbiology-Immunology Laboratories, University of North Carolina Hospitals, Chapel Hill, USA. celtsfan@med.unc.edu

Clinics in Laboratory Medicine
|November 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

American journal of respiratory and critical care medicine·2001
Same author

Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.

Bone marrow transplantation·2000
Same author

Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms.

The Journal of infectious diseases·1997
Same author

The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome.

American journal of respiratory and critical care medicine·1997
Same author

Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration.

Pediatric pulmonology·1997
Same author

Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.

Journal of clinical microbiology·1996

Escherichia coli (E. coli) causes diarrhea through various mechanisms, including toxin production and intestinal disruption. Prevention relies on sanitation, safe food handling, and avoiding contaminated water, especially for travelers.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Escherichia coli (E. coli) is a bacterium that can cause diarrheal disease through multiple pathogenic mechanisms.
  • Fecal contamination of food and water serves as the primary transmission route for E. coli infections in humans.
  • E. coli infections pose a significant public health risk, particularly in developing countries where they contribute to infant mortality.

Purpose of the Study:

  • To outline the diverse pathogenic mechanisms of E. coli leading to diarrheal disease.
  • To identify the sources and transmission routes of E. coli infections.
  • To discuss the implications for public health, especially concerning travelers and infants in endemic regions.

Main Methods:

  • Review of established knowledge on E. coli pathogenesis.

Related Experiment Videos

  • Analysis of transmission pathways via contaminated food and water.
  • Evaluation of disease impact and treatment strategies.

    • Main Results:

    • E. coli causes diarrhea via intestinal invasion, enterotoxin production, Shiga toxin (STx) production, and adherence leading to epithelial disruption.
    • Infections are primarily acquired through fecally contaminated food and water.
    • While often self-limiting in adults and treatable with oral rehydration, E. coli is a major cause of infant mortality in developing nations.

    Conclusions:

    • Effective prevention strategies include robust sanitation and safe food handling practices.
    • Travelers to endemic areas should exercise caution regarding food and water consumption.
    • Understanding E. coli's varied mechanisms is crucial for targeted prevention and treatment efforts.